Stocks TelegraphStocks Telegraph
Stock Ideas

SER Stock Performance and Key Statistics

AMEX : SER

Serina Therapeutics

$1.77
-0.03-1.67%
At Close 4:00 PM

stock performance chart

SER Fundamental Analysis

Based on recent data, Serina Therapeutics, Inc. (SER) shows an Average True Range (ATR) of 0.27 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 1.27M, indicating liquidity. These fundamental metrics provide insight into SER's underlying financial health and market activity.

ATR0.27
Enterprise Value-
Avg Vol (3 Months)1.27M
Avg Vol (10 Days)63.71K

SER Technical Analysis Indicators

Serina Therapeutics, Inc. (SER) technical indicators as of March 3, 2026: the SMA 20 is -16.18%, SMA 50 at -25.13%, and SMA 200 at -59.25%. The RSI 14 value is 40.43, suggesting its current momentum. These technical analysis signals help assess SER's price trends and potential future movements.

SMA 20-16.18%
SMA 50-25.13%
SMA 200-59.25%
RSI 1440.43

SER Stock Performance Overview

Serina Therapeutics, Inc. (SER) stock performance overview as of March 3, 2026: The 52-week high is $7.92 (currently -77.15% below), and the 52-week low is $1.53 (currently 17.98% above). Over the past year, SER's performance is -40.33%, compared to the S&P 500's 12.64% change.

52-Week High7.92
52-Week High Chg-77.15%
52-Week Low1.53
52-Week Low Chg+17.98%
S&P 500 52-Week Chg12.64%

Serina Therapeutics, Inc. (SER) Historical Stock Performance

According to market data, Serina Therapeutics, Inc. (SER) stock's recent performance metrics show that over the last month, SER is -2.38%, with a Year-to-Date (YTD) performance of 50.03%. Over the past year, the stock has seen a -40.33% change. These figures summarize SER's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High1.863.454.265.837.924.08
Low1.531.531.531.531.531.53
Performance+16.19%-2.38%-40.31%-46.36%-40.33%+50.03%

Industry Analysis and Valuation

According to current financial data, SER stock's P/E (TTM) ratio is -0.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for SER, including P/S (162.25), P/B (10.25), and P/FCF (-1.14), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationSERSector MedianIndustry AvgS&P 500
P/E (TTM)-0.97-1.23-5.1632.59
P/S (TTM)162.253.71464.925.98
P/B (TTM)10.254.467.564.85
P/FCF (TTM)-1.14-8.36-225.3433.82

Frequently Asked Questions

How is SER price-to-earnings ratio currently?
SER has a current P/E ratio of -0.97
How are SER's price-to-sale and price-to-book ratios?
The SER stock has a trailing twelve month price-to sales (P/S) ratio of 162.25 while its price-to-book (P/B) value is 10.25.
Is Serina Therapeutics, Inc.'s price-to-cashflow ratio high or low?
SER's price-to-free-cashflow (P/FCF) ratio is -1.14, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for SER?
Based on SER's recent bid, its distance from 20 days simple moving average is -16.18%. It is -25.13% apart from 50 days simple moving average, and it is -59.25% apart from 200 days simple moving average.
What is the 52-week price range for SER?
The 52-week high for SER is $7.92 which is -77.15% away from the current price level whereas the distance of that from the 52-week low of $1.53 stands at 17.98%.
An overview of SER's stock performance: how did it fare?
The performance of SER stock was not encouraging with most of its significant price indicators in green. Serina Therapeutics, Inc.(AMEX: SER) shares have moved downward -1.67% or - $0.03 in the latest trading session and have gained 50.03% year-to-date (YTD). The stock has lost nearly -40.33% over the past year. After moving -40.31% over the trailing 3-month period, the stock is -46.36% lower in the 6-month period. Looking at its performance over the shorter term, it'sgained 16.19% a week and -2.38% a month.
What is SER's 14-day relative strength index (RSI)?
The current 14-day RSI for SER stock is 40.43. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For SER, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Serina Therapeutics, Inc. (SER) has a 14-day ATR of 0.27.
What is SER's current enterprise value?
After closing at $1.80 with 10.79M of its shares outstanding, the current enterprise value of SER is roughly -.
Over the past year, how has the stock price of SER changed?
Serina Therapeutics, Inc. (AMEX: SER) is down -40.33% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 12.64%. SER stock price is also up 50.03% on its value in year-to-date trading.
What is the average trading volume for SER shares?
The number outstanding shares of SER is 10.79M, and of these 30.01% shares are freely available for trading. On average, SER stock has traded 63.71K shares per day for the past 10 days. A total of 55.19K shares changed hands during the last trading session with the average session volume of 1.4M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph